These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23636838)

  • 1. Chemical drug stability in lipids, modified lipids, and polyethylene oxide-containing formulations.
    Stella VJ
    Pharm Res; 2013 Dec; 30(12):3018-28. PubMed ID: 23636838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
    Cole ET; Cadé D; Benameur H
    Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K; Sistla R; Shastri NR
    Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of hard gelatin capsule shells filled with polyethylene glycol matrices.
    Stein D; Bindra DS
    Pharm Dev Technol; 2007; 12(1):71-7. PubMed ID: 17484146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid Based Formulations in Hard Gelatin and HPMC Capsules: a Physical Compatibility Study.
    Koehl NJ; Shah S; Tenekam ID; Khamiakova T; Sauwen N; Vingerhoets S; Coppenolle H; Holm R
    Pharm Res; 2021 Aug; 38(8):1439-1454. PubMed ID: 34378150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Activated Carbon in Packaging to Attenuate Formaldehyde-Induced and Formic Acid-Induced Degradation and Reduce Gelatin Cross-Linking in Solid Dosage Forms.
    Colgan ST; Zelesky TC; Chen R; Likar MD; MacDonald BC; Hawkins JM; Carroll SC; Johnson GM; Space JS; Jensen JF; DeMatteo VA
    J Pharm Sci; 2016 Jul; 105(7):2027-31. PubMed ID: 27262203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vitro dissolution of theophylline from different types of hard shell capsules.
    Podczeck F; Jones BE
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1163-9. PubMed ID: 12455475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of clinical dosage forms for a poorly water-soluble drug II: formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug.
    Li P; Hynes SR; Haefele TF; Pudipeddi M; Royce AE; Serajuddin AT
    J Pharm Sci; 2009 May; 98(5):1750-64. PubMed ID: 18781639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forced degradation study and characterization of main impurities of ibuprofen soft gelatin capsules by LC-MS-QTOF.
    Farias FF; Martins VAP; Dörr FA; Trujillo LM; Pinto E
    Pharmazie; 2021 Apr; 76(4):138-144. PubMed ID: 33849697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral lipid-based formulations.
    Hauss DJ
    Adv Drug Deliv Rev; 2007 Jul; 59(7):667-76. PubMed ID: 17618704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of hydroalcoholic solutions of formaldehyde in preparation of acetylsalicylic acid gastro-resistant capsules.
    Pina ME; Sousa AT
    Drug Dev Ind Pharm; 2002 Apr; 28(4):443-9. PubMed ID: 12056537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of hydroperoxides in common pharmaceutical excipients.
    Wasylaschuk WR; Harmon PA; Wagner G; Harman AB; Templeton AC; Xu H; Reed RA
    J Pharm Sci; 2007 Jan; 96(1):106-16. PubMed ID: 16917844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semisolid matrix filled capsules: an approach to improve dissolution stability of phenytoin sodium formulation.
    El Massik MA; Abdallah OY; Galal S; Daabis NA
    Drug Dev Ind Pharm; 2003 May; 29(5):531-43. PubMed ID: 12779283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative Manufacturing Concepts for Solid Oral Dosage Forms From Drug Nanosuspensions Using Fluid Dispensing and Forced Drying Technology.
    Bonhoeffer B; Kwade A; Juhnke M
    J Pharm Sci; 2018 Mar; 107(3):909-921. PubMed ID: 29154900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ lyophilisation of nifedipine directly in hard gelatine capsules.
    Crum M; Elkordy AA; Zarara M; Elkordy EA
    Pharm Dev Technol; 2013; 18(6):1379-90. PubMed ID: 22992055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Relative Permittivity Approach for Fast Drug Solubility Screening of Solvents and Excipients in Lipid-Based Delivery.
    Niederquell A; Dujovny G; Probst SE; Kuentz M
    J Pharm Sci; 2019 Oct; 108(10):3457-3460. PubMed ID: 31255684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and enhancement of physical stability of semi-solid dispersions containing piroxicam into hard gelatin capsules.
    Karataş A; Bekmezci S
    Acta Pol Pharm; 2013; 70(5):883-97. PubMed ID: 24147368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution.
    Mohsin K; Long MA; Pouton CW
    J Pharm Sci; 2009 Oct; 98(10):3582-95. PubMed ID: 19130605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyoxylglycerides and glycerides: effects of manufacturing parameters on API stability, excipient functionality and processing.
    Jannin V; Rodier JD; Musakhanian J
    Int J Pharm; 2014 May; 466(1-2):109-21. PubMed ID: 24607211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rectal administration of drugs.
    Senior N
    Adv Pharm Sci; 1974; 4():363-435. PubMed ID: 4618035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.